Heron Therapeutics

(NASDAQ) HRTX

Current Price$1.21

Market Cap$224.48M

Since IPO (1987)-100%

5 Year-93%

1 Year-49%

1 Month+60%

Heron Therapeutics Financials at a Glance

Market Cap

$224.48M

Revenue (TTM)

$154.90M

Net Income (TTM)

$20.20M

EPS (TTM)

$-0.12

P/E Ratio

-9.88

Dividend

$0.00

Beta (Volatility)

1.63 (High)

Dividend

$0.00

Beta (Volatility)

1.63 (High)

Price

$1.21

Volume

792,943.368

Open

$1.20

Price

$1.21

Volume

792,943.368

Open

$1.20

Previous Close

$1.19

Daily Range

$1.16 - $1.21

52-Week Range

$0.74 - $2.61

Dividend

$0.00

Beta (Volatility)

1.63 (High)

Price

$1.21

Volume

792,943.368

Open

$1.20

Previous Close

$1.19

Daily Range

$1.16 - $1.21

52-Week Range

$0.74 - $2.61

HRTX News

Under Biden's Budget, These 2 Little-Known Biotechs Could Help End the Opioid Crisis

Jason HawthorneJun 2, 2021

Page 1

HRTX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Heron Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

128

CEO

Craig A. Collard

Website

www.herontx.com

Headquarters

Cary, CA 92121, US

HRTX Financials

Key Financial Metrics (TTM)

Gross Margin

73%

Operating Margin

-2%

Net Income Margin

-13%

Return on Equity

Return on Capital

-2%

Return on Assets

-8%

Earnings Yield

-10.12%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$224.48M

Shares Outstanding

188.64M

Volume

792.94K

Avg. Volume

1.92M

Financials (TTM)

Gross Profit

$113.56M

Operating Income

$2.54M

EBITDA

$17.88M

Operating Cash Flow

$27.59M

Capital Expenditure

$317.00K

Free Cash Flow

$27.91M

Cash & ST Invst.

$46.63M

Total Debt

$140.64M

Heron Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$40.59M

-0.5%

Gross Profit

$32.94M

+7.8%

Gross Margin

81.15%

N/A

Market Cap

$224.48M

N/A

Market Cap/Employee

$1.84M

N/A

Employees

122

N/A

Net Income

$2.95M

-180.6%

EBITDA

$792.00K

-109.1%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$94.01M

+20.7%

Accounts Receivable

$89.59M

+13.6%

Inventory

$92.75M

+74.5%

Long Term Debt

$140.64M

-19.5%

Short Term Debt

$0.00

-100.0%

Return on Assets

-7.89%

N/A

Return on Invested Capital

-1.59%

N/A

Free Cash Flow

$9.18M

+26.0%

Operating Cash Flow

$9.18M

+22.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CHRSCoherus Oncology, Inc.

CHRSCoherus Oncology, Inc.$1.78+2.30%

TARAProtara Therapeutics, Inc.

TARAProtara Therapeutics, Inc.$5.29+2.42%

IVVDInvivyd, Inc.

IVVDInvivyd, Inc.$1.43+4.78%

EPRXEupraxia Pharmaceuticals Inc.

EPRXEupraxia Pharmaceuticals Inc.$7.84+6.88%

MDWDMediWound Ltd.

MDWDMediWound Ltd.$16.48+1.42%

OABIOmniAb, Inc.

OABIOmniAb, Inc.$1.39+1.84%

NTHINeonc Technologies Holdings, Inc.

NTHINeonc Technologies Holdings, Inc.$4.40+2.33%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.69+0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.57+0.08%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.54+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.56+0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$51.64-0.03%

HCAIHuachen Ai Parking Management Technology

HCAIHuachen Ai Parking Management Technology$10.39+0.90%

GGLSDirexion Shares ETF Trust - Direxion Daily Googl Bear 1x Shares

GGLSDirexion Shares ETF Trust - Direxion Daily Googl Bear 1x Shares$5.46-0.09%

Questions About HRTX

What is the current price of Heron Therapeutics?

Heron Therapeutics is trading at $1.21 per share.

What is the 52-week range for Heron Therapeutics?

Over the past 52 weeks, Heron Therapeutics has traded between $0.74 and $2.61.

How much debt does Heron Therapeutics have?

As of the most recent reporting period, Heron Therapeutics reported total debt of $140.64M.

How much cash does Heron Therapeutics have on hand?

Heron Therapeutics reported $28.65M in cash and cash equivalents in its most recent financial results.

What is Heron Therapeutics’s dividend yield?

Heron Therapeutics does not currently have a dividend yield.

Heron Therapeutics

Heron Therapeutics Financials at a Glance

HRTX News

Heron (HRTX) Q2 Acute Care Jumps 56%

These 2 Growth Stocks Might Be Incredibly Undervalued Right Now

Why Heron Therapeutics Stock Has Been on Fire This Week

Why Shares of Heron Therapeutics Jumped Thursday

Why Heron Therapeutics Stock Is Getting Hammered Today

Why Heron Therapeutics Shares Rose Nearly 15% This Week

Bluebird Bio or Heron Therapeutics: Which Stock Is the Better Comeback Play?

Under Biden's Budget, These 2 Little-Known Biotechs Could Help End the Opioid Crisis

HRTX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Heron Therapeutics

HRTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Heron Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HRTX

What is the current price of Heron Therapeutics?

What is the 52-week range for Heron Therapeutics?

How much debt does Heron Therapeutics have?

How much cash does Heron Therapeutics have on hand?

What is Heron Therapeutics’s dividend yield?

Premium Investing Services